PANA · Panacea Acquisition Corp. II - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - |
| Total Operating Expenses | - | $214.6K | $231.2K | $307.7K | - | $215.9K | $226.7K | $5.0K |
| D&A | - | - | - | - | - | - | - | - |
| Operating Income | - | ($214.6K) | ($231.2K) | ($307.7K) | - | ($215.9K) | ($226.7K) | - |
| Interest Expense | - | - | - | - | - | - | - | - |
| Income Tax | - | - | - | - | - | - | - | - |
| Net Income | - | $649.8K | ($153.0K) | ($303.4K) | - | ($212.3K) | ($224.9K) | ($5.0K) |
| EPS - Basic | - | - | - | ($0.01) | - | - | - | - |
| EPS - Diluted | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $70.0K | $101.0K | $134.3K | $280.9K | $353.1K | $635.0K | $670.8K | - |
| Accounts Receivable | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - |
| Current Assets | $207.9K | $392.2K | $578.7K | $636.6K | $1.05M | $1.48M | $1.67M | - |
| Total Assets | $175.12M | $173.85M | $173.17M | $173.38M | $173.55M | $173.98M | $174.17M | $422.5K |
| Current Liabilities | $433.7K | $396.5K | $368.4K | $427.0K | $296.2K | $430.0K | $401.9K | $402.5K |
| Long-term Debt | - | - | - | - | - | - | - | - |
| Total Liabilities | $6.47M | $6.43M | $6.41M | $6.46M | $6.33M | $6.47M | $6.44M | - |
| Stockholders' Equity | ($6.26M) | ($6.04M) | ($5.83M) | ($5.28M) | ($5.28M) | ($4.98M) | $5.00M | $20.0K |
| Retained Earnings | ($6.26M) | ($6.04M) | ($5.83M) | ($5.58M) | ($5.28M) | ($4.99M) | ($229.9K) | ($5.0K) |
Cash Flow
| Line item | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | ($72.2K) | - | - | - | - |
| Investing Cash Flow | - | - | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - | - | - |
| CapEx | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||
| Gross margin | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - |
| Return on assets | - | 0.4% | -0.1% | -0.2% | - | -0.1% | -0.1% | -1.2% |
| Return on equity | - | -10.8% | 2.6% | 5.7% | - | 4.3% | -4.5% | -25.0% |
| Return on invested capital | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||
| Current ratio | 0.48 | 0.99 | 1.57 | 1.49 | 3.53 | 3.44 | 4.14 | - |
| Quick ratio | 0.48 | 0.99 | 1.57 | 1.49 | 3.53 | 3.44 | 4.14 | - |
| Cash ratio | 0.16 | 0.25 | 0.36 | 0.66 | 1.19 | 1.48 | 1.67 | - |
| Leverage | ||||||||
| Debt / Equity | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - |
| Equity multiplier | -27.96 | -28.77 | -29.72 | -32.85 | -32.88 | -34.90 | 34.83 | 21.13 |
| Liabilities / Assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | - |
| Efficiency | ||||||||
| Asset turnover | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - |
| Valuation | ||||||||
| P / E | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| Growth | ||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | 0.6% | -2.0% | - | - | - | - | - |
| Net income growth (YoY) | - | - | 32.0% | -5968.5% | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -18.7% | -21.2% | - | - | - | - | - | - |
Peer comparison
Same SIC group: Blank Checks
Comparing Panacea Acquisition Corp. II against the 5 most active filers in the same SIC group.